Fluoroquinolones for the treatment and prevention of multidrug-resistant tuberculosis.

Sterling TR
Int J Tuberc Lung Dis. 2016 20 (12): 42-47

PMID: 28240572 · DOI:10.5588/ijtld.16.0117

MeSH Terms (9)

Antitubercular Agents Clinical Trials as Topic Dose-Response Relationship, Drug Fluoroquinolones Humans Levofloxacin Moxifloxacin Treatment Outcome Tuberculosis, Multidrug-Resistant

Connections (1)

This publication is referenced by other Labnodes entities:

Links